2026 Annual Meeting | S22 - Neuroinfectious Disease: Basic Sciences
| 01:00 PM - 01:12 PM CDT | Speaker |
2026 AAN Neuro-infectious Disease Award: This award recognizes individuals who have made a contribution to neuro-infectious disease research
Yair Mina, MD |
| Shibani S. Mukerji, MD, PhD | Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has stock in Gilead Science. Dr. Mukerji has stock in Ranpack. Dr. Mukerji has stock in Snowflake. An immediate family member of Dr. Mukerji has stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
| Sasha Gupta, MD | Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Yair Mina, MD | Dr. Mina has nothing to disclose. |